Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.12M Buy
17,396
+684
+4% +$244K 0.25% 76
2025
Q4
$5.47M Buy
16,712
+28
+0.2% +$8.88K 0.23% 73
2025
Q3
$4.71M Buy
16,684
+148
+0.9% +$42.9K 0.2% 88
2025
Q2
$4.62M Buy
16,536
+432
+3% +$122K 0.23% 85
2025
Q1
$5.02M Sell
16,104
-492
-3% -$145K 0.27% 75
2024
Q4
$4.33M Buy
16,596
+1,675
+11% +$497K 0.24% 90
2024
Q3
$4.81M Buy
14,921
+72
+0.5% +$23.6K 0.28% 76
2024
Q2
$4.64M Buy
14,849
+7
+0% +$2.06K 0.3% 66
2024
Q1
$4.22M Buy
+14,842
New +$4.34M 0.29% 82

Other funds holding AMGN

Trajan Wealth's AMGN Position: Q1 2026 in Review

Trajan Wealth increased its Amgen (AMGN) stake by 4.1% in Q1 2026, buying an estimated $244K and bringing the position to 17,396 shares worth $6.12M. The position accounts for 0.25% of the portfolio, ranked #76.

Trajan Wealth first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Trajan Wealth held 17,396 shares of Amgen worth $6.12M as of Q1 2026.
  • Trajan Wealth bought 684 Amgen shares in Q1 2026, an estimated $244K.
  • Amgen made up 0.25% of Trajan Wealth's portfolio in Q1 2026, its #76 holding.
  • Trajan Wealth first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Trajan Wealth's 13F filing for Q1 2026, filed 14 May 2026.